Year None20242023202220212020201920182017 Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates April 16, 2024 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases March 13, 2024
Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases March 13, 2024